Literature DB >> 9218085

Effect of acute pentoxifylline treatment in an experimental model of colitis.

T C Peterson1, K Davey.   

Abstract

BACKGROUND: The effect of acute pentoxifylline treatment in an experimental model of colitis was assessed using the trinitrobenzene sulphonic acid (TNBS)-induced rat model of colitis.
METHODS: Animals were treated with intracolonic injection (250 microliters) of TNBS (50 mg in 50% ethanol) to induce inflammation and ulcers. Animals received pentoxifilline (100 mg/kg intracolonically) or saline 24 and 48 h following TNBS treatment. Five days following TNBS treatment, colons were dissected and scored according to the morphology damage score. The colons were then rolled longitudinally, fixed in formalin and embedded in paraffin. The collagen content of colonic sections were determined by a Sirius red-Fast green technique.
RESULTS: Animals treated with TNBS alone had significantly higher gross morphology damage scores compared to animals treated with saline. Pentoxifylline significantly reduced the gross morphology damage score in animals receiving TNBS. Colonic collagen levels were significantly elevated in TNBS-treated animals compared to animals receiving saline. Pentoxifylline treatment did not alter the collagen content of colons from TNBS-treated animals.
CONCLUSION: TNBS treatment significantly elevates morphology damage score compared to controls. The results also suggest that colonic collagen was significantly elevated in animals treated with TNBS compared to controls. Pentoxifylline treatment was not sufficient to reduce the elevation in colonic collagen, although pentoxifylline treatment was sufficient to reduce the pathological changes due to TNBS, thus bringing the morphology damage score down to control levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218085     DOI: 10.1046/j.1365-2036.1997.00188.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat.

Authors:  T C Peterson; C E Cleary; A M Shaw; D A Malatjalian; S J Veldhuyzen van Zanten
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity.

Authors:  N Diaz-Granados; K Howe; J Lu; D M McKay
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 4.  Proposed therapies in primary biliary cholangitis.

Authors:  Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-01-06       Impact factor: 3.869

Review 5.  Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease.

Authors:  In-Ah Lee; Alan Kamba; Daren Low; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

6.  Evaluating the effects of pentoxifylline administration on experimental pressure sores in rats by biomechanical examinations.

Authors:  Kobra Velaei; Mohammad Bayat; Giti Torkman; Fatemealsadat Rezaie; Abdollah Amini; Mohsen Noruzian; Azaedh Tavassol; Mehernoush Bayat
Journal:  Lab Anim Res       Date:  2012-09-26

7.  Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon.

Authors:  Cristina Segnani; Chiara Ippolito; Luca Antonioli; Carolina Pellegrini; Corrado Blandizzi; Amelio Dolfi; Nunzia Bernardini
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

8.  Transcribed ultraconserved region (T-UCR) uc.261 expression is closely correlated with disease activity and intestinal permeability in Crohn's disease.

Authors:  Xiao-Xian Qian; Chen-Wen Cai; Han-Yang Li; Li-Jie Lai; Dong-Juan Song; Yu-Qi Qiao; Jun Shen; Zhi-Hua Ran
Journal:  Therap Adv Gastroenterol       Date:  2019-10-16       Impact factor: 4.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.